Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Dividends payables came in at $1.7 million in Q1 2026, down 0.56% quarter-over-quarter from $1.7 million in Q1 2021.
Analysis
Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Dividends payables for 3 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Dividends payables changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Jan 2026 stood at $1.7 million (changed N/A YoY), and the FY2019 full-year result was $1.7 million, changed N/A from the prior year.
- Dividends payables declined to $1.7 million in Q1 2026 per PBSV's latest filing, from $1.7 million in the prior quarter.
- Across five years, Dividends payables topped out at $1.7 million in Q1 2026 and bottomed at $1.7 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | - |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | - |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | - |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | - |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | - |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | - |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | - |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | - |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2026 | 1.72 Mn |
| Jan 31, 2021 | 1.73 Mn |
| Oct 31, 2019 | 1.73 Mn |